Clinical characteristics of dengue and dengue hemorrhagic fever in a medical center of southern Taiwan during the 2002 epidemic

Journal of Microbiology, Immunology and Infection

Volumn 39, Issue 2, 2006, Pages 121-129

  Lee, Min Sheng ^a   Hwang, Kao Pin ^b   Chen, Tun Chieh ^a   Lu, Po Lian ^a   Chen, Tyen Po ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Dengue hemorrhagic fever; Dengue virus; Taiwan

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DENGUE; DIABETES MELLITUS; DISEASE SEVERITY; EPIDEMIC; FEMALE; HOSPITAL; HUMAN; HYPERTENSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; TAIWAN; UREMIA;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; DENGUE; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; DIABETES COMPLICATIONS; DISEASE OUTBREAKS; FEMALE; HUMANS; HYPERTENSION; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INCIDENCE; INFANT; MALE; MIDDLE AGED; RISK FACTORS; TAIWAN; UREMIA;

EID: 33745432076     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ko YC. Epidemiology of dengue fever in Taiwan [in Chinese]. Gaoxiong Yi Xue Ke Xue Za Zhi 1989;5:1-11.
2. Hwang KP. Dengue fever and dengue hemorrhagic fever. Formosan J Med 1997;1:50-6.
3. King CC, Wu YC, Chao DY, Lin TH, Chow L, Wang HT, et al. Major epidemics of dengue in Taiwan in 1991-2000: related to intensive virus activities in Asia. Dengue Bull. Geneva: WHO 2000;24:1-10.
4. Hwang KP, Su SC, Chiang CH. Clinical observations of dengue fever among children [in Chinese]. Gaoxiong Yi Xue Ke Xue Za Zhi 1989;5:50-7.
5. Center for Disease Control, Taiwan. Bulletin statistics of communicable diseases and surveillance report in Taiwan area, 2002. Department of Health, The Executive Yuan, Taiwan, 2004.
6. Lei HY, Huang JH, Huang KJ, Chang C. Status of dengue control programme in Taiwan-2001. Dengue Bull. Geneva: World Health Organization 2002;26:14-23.
7. World Health Organization (WHO). Dengue hemorrhagic fever: diagnosis, treatment, and control. Geneva: WHO; 1997.
8. Pan American Health Organization (PAHO). Dengue and dengue hemorrhagic fever in the Americas: guidelines for prevention and control. Washington, DC: PAHO; 1994.
9. Chareonsook O, Foy HM, Teeraratkul A, Silarug N. Changing epidemiology of dengue hemorrhagic fever in Thailand. Epidemiol Infect 1999;122:161-6.
10. Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science 1988;239:476-81.
11. Bravo JR, Guzman MG, Kouri GP. Why dengue haemorrhagic fever in Cuba? 1. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). Trans R Soc Trop Med Hyg 1987;81:816-20.
12. Wei JN, Chuang LM, Lin RS, Chao CL, Sung FC. Prevalence and hospitalization rate of diabetes mellitus in Taiwan, 1996-2000. Taiwan J Public Health 2002;21:173-80.
13. Alvarez ME, Ramirez-Ronda CH. Dengue and hepatic failure. Am J Med 1985;7:670-4.
14. Nguyen TL, Nguyen TH, Tieu NT. The impact of dengue haemorrhagic fever on liver function. Res Virol 1997;148: 273-7.
15. Kuo CH, Tai DI, Chang-Chien CS, Lan CK, Chiou SS, Liaw YF. Liver biochemical tests and dengue fever. Am J Trop Med Hyg 1992;47:265-70.
16. Patriquin HB, DiPietro M, Barber FE, Teele RL. Sonography of thickened gallbladder wall: causes in children. AJR Am J Roentgenol 1983;141:57-60.
17. Carroll BA. Gallbladder wall thickening secondary to focal lymphatic obstruction. J Ultrasound Med 1983;2:89-91.
18. Fitzgerald EJ, Toi A. Pitfalls in the ultrasonographic diagnosis of gallbladder diseases. Postgrad Med J 1987;63:525-32.
19. Ekberg O, Weiber S. The clinical importance of a thick-walled, tender gall-bladder without stones on ultrasonography. Clin Radiol 1991;44:38-41.
20. Maudgal DP, Wansbrough-Jones MH, Joseph AE. Gallbladder abnormalities in acute infectious hepatitis. A prospective study. Dig Dis Sci 1984;29:257-60.
21. Saverymuttu SH, Grammatopoulos A, Meanock CI, Maxwell JD, Joseph AE. Gallbladder wall thickening (congestive cholecystopathy) in liver disease; a sign of portal hypertension. Br J Radiol 1990;62:922-5.
22. Tassniyom S, Vasanawathana S, Chirawatkul A, Rojanasuphot S. Failure of high-dose methylprednisolone in established dengue shock syndrome: a placebo-controlled, double-blind study. Pediatrics 1993;92:111-5.
23. Halstead SB. Epidemiology of dengue and dengue hemorrhagic fever. In: Gubler DJ, Kuno G, eds. Dengue and dengue hemorrhagic fever. Wallingford, UK: CAB International; 1997: 23-44.
24. Isturiz RE, Gubler DJ, Brea del Castillo J. Dengue and dengue hemorrhagic fever in Latin America and the Caribbean. Infect Dis Clin North Am 2000;14:121-40.
25. Rigau-Perez JG. Clinical manifestations of dengue hemorrhagic fever in Puerto Rico, 1990-1991. Puerto Rico Association of Epidemiologists. Rev Panam Salud Publica 1997;1:381-8.
26. Pang T. Vaccines for the prevention of neglected diseases-dengue fever. Curr Opin Biotechnol 2003;14:332-6.